I think it will take really good Phase 2 study results for Zenith Epi to have a decent chance at a buyout.  And looking through the MD&A, it seems the major "data flow" will be in 2024.  So 2025 would be my earliest realistic hope for something to happen.  Hopefully they can keep the lights on til then.

Dec MD&A

"....In summary, ZEN-3694 combination therapies are being developed in multiple solid tumor indications through either company sponsored trials or investigator-initiated trials. There will be significant data flow in calendar 2024 from these multiple trials and will inform the development and registration path of ZEN-3694 in multiple indications...."